Torrent Pharmaceuticals Limited
TORNTPHARM.NS
₹4848.00
▼ 1.17%
Torrent Pharmaceuticals bucked the sector trend, falling 1.17% to ₹4848.00 even as no specific news emerged to explain the pullback. The stock's longer-term trajectory has been consistently strong regardless, with returns of 34.75% over one year, 18.35% over two years, and compounding near 24.88% and 19.52% annually across five and ten years. Analysts remain constructive on the name too, with a buy consensus from 29 analysts and an average target of ₹5386.76, well above where the stock trades today.
CAGR Performance
| 1 Year | 2 Years | 5 Years | 10 Years |
|---|---|---|---|
| 34.94% | 18.43% | 24.92% | 19.53% |
Analyst Consensus
Average Target Price: ₹5386.76 (range ₹4150.00 - ₹6194.00) based on 29 analysts
Strong Buy: 7
Buy: 16
Hold: 5
Sell: 0
Strong Sell: 1
Related News
| Sep 4, 2026 | Torrent Pharmaceuticals Limited Share Price Falls 1.41% (Sep 3, 2026) |
| May 5, 2026 | Algorae Pharmaceuticals Executes License & Supply Agreement With Torrent Pharma |
No comments:
Post a Comment